Merck KGaA is in the investment-grade market Tuesday, a day after holding investor calls, to help fund its $3.9 billion ...

North America Leads Today, Asia Pacific to Record Fastest GrowthThe global high throughput screening market, valued at ...

Hexyl Acetate Market UK CAGR rises from 2.5% to 3.8% by 2035, driven by natural fragrances, premium skincare, body sprays, and innovative f ...

Thermo Fisher Scientific Inc. maintains global leadership through an extensive portfolio of automated systems, screening instruments, and consumables, underpinned by 3% annual R&D investment and ...

Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for ...

Over the past six months, Merck’s stock price fell to $80.05. Shareholders have lost 6.6% of their capital, which is ...

This week, Merck filed a notice in accordance with New Jersey's WARN Act, indicating it plans to eliminate 58 positions at ...

Pfizer (PFE) stock is in focus as the company and Astellas (ALPMF) post a late-stage trial win for their cancer drug Padcev ...

Merck in 2019 inked a deal to evaluate the combination of its blockbuster cancer drug Keytruda with Pacdev from Astellas and Seagen, which Pfizer acquired in a $43 billion deal that closed in late ...

The Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and Merck are joining forces to establish a leading innovation hub for cybersecurity in Europe by 2030.